Ted Torphy, PhD

Dr. Ted Torphy oversees the preclinical program development and translation at Ultimate Medicine. He serves on the Scientific Advisory Board and has over 35 years of experience in the Pharmaceutical and Biotechnology industry. Dr. Torphy was formerly CEO and CSO of BioMotiv, a for-profit drug development accelerator associated with The Harrington Project. Prior to joining BioMotiv, he spent 12 years with Johnson & Johnson. Dr. Torphy’s roles included Global Head of External Innovation & Business Models for Discovery Sciences, Vice President and Head of External Research and Early Development, Corporate Vice President and Head of Johnson & Johnson’s Corporate Office of Science & Technology, and Senior Vice President and Head of Discovery and Preclinical Development at Centocor, the biopharmaceutical arm of Johnson & Johnson. Prior to joining Johnson & Johnson, Dr. Torphy spent 17 years with SmithKline Beecham, most recently as Vice President and Head of Biological Research for the Cardiovascular, Metabolic, Pulmonary, Renal and Inflammatory Diseases therapeutic areas. He currently chairs or is a member of boards of several for-profit and non-profit organizations. Dr. Torphy holds a BS degree in Pharmacy from the University of Wisconsin and a PhD in Pharmacology and Toxicology from West Virginia University. He completed his postdoctoral training at the University of California, San Diego.